Is It Safe to Conclude that Beers Criteria Medications Led to Few Adverse Events?

  1. Daniel S. Budnitz, MD, MPH;
  2. Nadine Shehab, PharmD;
  3. Scott R. Kegler, PhD; and
  4. Chesley L. Richards, MD, MPH
  1. From the Centers for Disease Control and Prevention, Atlanta, GA 30333.

    IN RESPONSE:

    We thank Dr. Golden and colleagues for their response to our recent article. They brought up several interesting issues, but we believe the critical issue for patient safety is identified by Dr. Krishnamurthy in his online letter (1). The estimated 59 000 emergency department visits each year caused by adverse events from the use of insulin, warfarin, and digoxin are harms that should be addressed. We stand by our conclusions that performance measures and interventions targeting the use of warfarin, insulin, and digoxin could prevent more emergency …

    « Previous | Next Article »Table of Contents